BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7055097)

  • 1. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.
    Jaffe ES; Strauchen JA; Berard CW
    Am J Clin Pathol; 1982 Jan; 77(1):46-9. PubMed ID: 7055097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
    Cossman J; Jaffe ES; Fisher RI
    Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.
    Said JW; Hargreaves HK; Pinkus GS
    Cancer; 1979 Aug; 44(2):504-28. PubMed ID: 383256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
    Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
    Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.
    Frizzera G; Gajl-Peczalska KJ; Bloomfield CD; Kersey JH
    Cancer; 1979 Apr; 43(4):1216-24. PubMed ID: 376087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant lymphoma in Hawaii-Japanese: a retrospective morphologic survey.
    Yanagihara ET; Blaisdell RK; Hayashi T; Lukes RJ
    Hematol Oncol; 1989; 7(3):219-32. PubMed ID: 2707745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, morphologic, immunophenotypic, and molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasms in 17 patients.
    McNally L; Jakobiec FA; Knowles DM
    Am J Ophthalmol; 1987 Apr; 103(4):555-68. PubMed ID: 3494404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiinstitution study of non-Hodgkin's lymphomas using frozen section immunoperoxidase: the Southeastern Cancer Study Group experience.
    Borowitz MJ; Newby S; Brynes RK; Cousar JB; Whitcomb CC; Crissman JD; Byrne GE; Collins RD
    Blood; 1984 May; 63(5):1147-52. PubMed ID: 6370333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large cell lymphomas (reticulum cell sarcomas, histiocytic lymphomas). Correlation of morphologic features with functional markers.
    Azar HA; Jaffe ES; Berard CW; Callihan TR; Braylan RR; Cossman J; Triche TJ
    Cancer; 1980 Sep; 46(6):1428-41. PubMed ID: 6998555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
    Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
    Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic reticulum cells and immunophenotype in aspiration biopsies of lymph nodes. Value in the subclassification of non-Hodgkin's lymphomas.
    Kornstein MJ; Wakely PE; Kardos TF; Frable WJ
    Am J Clin Pathol; 1990 Aug; 94(2):165-9. PubMed ID: 2196777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility in morphologic classification of non-Hodgkin's lymphomas using the Lukes-Collins system. The Southeastern Cancer Study Group experience.
    Whitcomb CC; Crissman JD; Flint A; Cousar JB; Collins RD; Byrne GE
    Am J Clin Pathol; 1984 Oct; 82(4):383-8. PubMed ID: 6475834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects.
    Yamanaka N; Harabuchi Y; Sambe S; Shido F; Matsuda F; Kataura A; Ishii Y; Kikuchi K
    Cancer; 1985 Aug; 56(4):768-76. PubMed ID: 4016670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
    Harris NL; Nadler LM; Bhan AK
    Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant lymphomas in Beijing.
    Ji X; Li W
    J Environ Pathol Toxicol Oncol; 1992; 11(5-6):327-9. PubMed ID: 1464816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic and immunologic characterization of malignant lymphoma in Taiwan. With special reference to retrovirus-associated adult T-cell lymphoma/leukemia.
    Su IJ; Shih LY; Kadin ME; Dun P; Hsu SM
    Am J Clin Pathol; 1985 Dec; 84(6):715-23. PubMed ID: 3000162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.